Synopsis of recent research by authors named "QianLi Tang"
- Recent research by Qianli Tang focuses on the development of advanced electrochemical biosensors that leverage CRISPR technology for the sensitive detection of various biomarkers related to health conditions including cancer, aging, and infectious diseases.
- Tang's work includes the design of innovative approaches such as the combination of electrochemiluminescence with CRISPR/Cas systems and amplification techniques, enabling specific detection of biomarkers like matrix metalloproteinase-2 (MMP-2), Escherichia coli, and apolipoprotein A4, which are crucial in cancer diagnosis and management.
- The findings suggest that these novel biosensor technologies not only provide enhanced detection capabilities but also contribute to the understanding of disease mechanisms, such as the role of fucosyltransferase-6 in esophageal carcinoma and the implications of tryptophan metabolism in hepatocellular carcinoma.
